248.633.81004 Boehringer Ingelheim Investigational Site

Sagamihara, Kanagawa

0 studies enrolling now · 1 studies all time

What they study most

Parkinson Disease

Studies at this site

• Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). — Completed